Published in
Springer Nature [academic journals on nature.com], Leukemia, 2(32), p. 383-390, 2017
DOI: 10.1038/leu.2017.211
Links
Tools
Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial
Journal article published in 2017 by
H. Goldschmidt,
H. M. Lokhorst,
E. K. Mai,
B. van der Holt 
,
I. W. Blau,
S. Zweegman,
K. C. Weisel,
E. Vellenga,
M. Pfreundschuh,
M. J. Kersten,
C. Scheid,
S. Croockewit,
R. Raymakers,
D. Hose,
A. Potamianou
and other authors.
,
I. W. Blau,
S. Zweegman,
K. C. Weisel,
E. Vellenga,
M. Pfreundschuh,
M. J. Kersten,
C. Scheid,
S. Croockewit,
R. Raymakers,
D. Hose,
A. Potamianou
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 